| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |